Panther Life Sciences
Panther is developing microarray patches (MAPs) for skin health and therapeutics, focusing on delivering effective, safe, and user-friendly treatments for conditions such as scars, wounds, and autoimmune diseases. The company is leveraging AI and advanced manufacturing to create accessible health solutions.
Headquarters
New York, New York, United States
Company Size
1-10 employees
Founded
2023
Panther Life Sciences Corporation is a company licensing and developing new treatment delivery methods using its proprietary dissolvable microarray patch (SmartMAP) technology. Rather than developing new compounds, Panther engineers superior delivery of already proven treatments, offering precise and controlled application into the skin without needles, pills, or refrigeration. The company targets large markets including clinical skincare, oncology, longevity/anti-aging, and dermal fillers, with a platform designed for self-application and direct-to-consumer distribution.
Panther Life Sciences will expand local presence after successful BioForge collaboration
Nov 12, 2025
Timeline: Pitt’s BioForge advances construction as first projects near completion
Oct 23, 2025
Pittsburgh Life Sciences Alliance CEO talks AI, region's health care edge - Pittsburgh Business Times
Jan 5, 2026
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Panther Life Sciences.
Panther Life Sciences didn’t post a salary, so this is our estimate from similar listings.
Panther Life Sciences partners with Pitt's BioForge on a product used to administer vaccines and other medicines
Feb 27, 2025